- Health Conditions
- Events
- MedWire
- Visit A Doctor
- Medimorphosis
- HCP Portal
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Respiratory
Tepotinib (Tepmetko) was recently approved for the use of Non-Small Cell Lung Cancer (NSCLC). We break down the results of Phase II VISION trial in this article.
Asthma is one of the most common chronic respiratory conditions treated in the primary care setting in Singapore. Critically, it…
What is COPD? Chronic Obstructive Pulmonary Disease (COPD) is the progressive decline of lung function due to emphysema and/or chronic…
Bronchiectasis is a serious condition affecting the lungs. This condition mainly affects people above 75 years old, though it is…
According to the World Health Organisation (WHO), COPD, short for Chronic Obstructive Pulmonary Disease, is the third major cause of…
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterised by irreversible airflow limitation and associated with significant…
Pneumonia is the leading cause of death caused by infectious diseases in the world and accounts for 15% of deaths…
Allergies affect up to 20 percent of the world’s population. The severity of allergies varies amongst individuals and can range…
Hot on the heels of sotrovimab, the Health Science’s Authority (HSA) has granted pandemic special access route (PSAR) interim authorization…
On 13 and 17 October 2020, COPDAS organised a webinar on improving quality of life in symptomatic COPD patients, as part of…
Subscribe to Updates
Subscribe to receive latest health related news from us
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.